Biochem. J. (2007) volume 406, issue 3, pages 389–398, https://doi.org/10.1042/BJ20070091
It has come to the attention of the authors that in the original Figure 2(D) the same images were used for GST-CK1δ1-428, GST-CK1δ1-428S370A and GST-CK1δ1-375 in the Coomassie-stained gel.
In the autoradiogram of Figure 2(D), PKA negative GST-CK1δ1-428, and PKA negative GST-CK1δ1-428S370A were the same, as were GST-CK1δ1-350 and GST-CK1δ1-375. This mistake has now been addressed and corrected.
In Figure 3(A) fraction number 14 of the control was accidentally used for fraction number 14 of H89, degeulin, and calphostin treatments. In addition, fraction number 13 of the control was erroneously used for fraction 13 in the deguelin treatment. Furthermore, fraction number 9 of the deguelin treatment was run on another gel, and the image was subsequently inserted into the Figure.
The authors are now presenting the corrected Figures 2(D) and 3(A), and would like to apologize for any confusion that these errors may have caused. The new Figures have been assessed and approved by the Editorial Board of the Biochemical Journal.
New Figure 2(D)
Phosphorylation of GST-CK1δ fusion proteins by PKA.
New Figure 3(A)
PKA is the major CK1δCK activity present in the kinase peak fraction of fractionated MiaPaCa-2 cells.
To support data shown in Figure 3(A), results from experiments carried out in May 2017 are now presented:
PKA is the major CK1δ CK activity present in the kinase peak fraction of fractionated MiaPaCa-2 cells
Phosphate incorporation in GST-CK1δ305-375 (FP1006) in the absence or presence of deguelin at 0.2 and 1.0 µM